Advanced Biomed (ADVB) Hisse Fiyat

Advanced Biomed Inc operates as a holding company focused on biochip technologies in the Health Care sector. Headquartered in Reno, Nevada, the company employs 40 full-time staff. It provides assay products and services for cancer patients, including early screening, diagnosis, treatment selection, and patient outcome interventions. The company has developed a microfluidic technology platform integrating R&D, design, and manufacturing of biochips. Its products include devices like A+Pre, AC-1000, A+CellScan, and A+SCDrop, along with corresponding microfluidic biochips such as A+Pre-Chip and AC-1000 CTC Enrichment Chip. The company went public on March 6, 2025.